Carnero A, Blanco-Aparicio C, Renner O et al (2008) The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8:187–198. https://doi.org/10.2174/156800908784293659

Article  CAS  PubMed  Google Scholar 

Chen LM, Karlan BY (1998) Early detection and risk reduction for familial gynecologic cancers. Clin Obstet Gynecol 41:200–214. https://doi.org/10.1097/00003081-199803000-00025

Article  CAS  PubMed  Google Scholar 

Chen CY, Chen J, He L et al (2018) PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (lausanne) 9:338. https://doi.org/10.3389/fendo.2018.00338

Article  PubMed  Google Scholar 

Chen Y, Liu L, Xia L et al (2022) TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation. J Exp Clin Cancer Res 41:44. https://doi.org/10.1186/s13046-022-02252-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coleridge SL, Bryant A, Kehoe S et al (2021) Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst Rev 7:CD005343. https://doi.org/10.1002/14651858.CD005343.pub6

Article  PubMed  Google Scholar 

Ediriweera MK, Tennekoon KH, Samarakoon SR (2019) Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance. Semin Cancer Biol 59:147–160. https://doi.org/10.1016/j.semcancer.2019.05.012

Article  CAS  PubMed  Google Scholar 

Fullar A, Baghy K, Deak F et al (2014) Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3beta pathways in vivo. PLoS ONE 9:e93469. https://doi.org/10.1371/journal.pone.0093469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Januchowski R, Zawierucha P, Rucinski M et al (2014) Microarray-based detection and expression analysis of extracellular matrix proteins in drug-resistant ovarian cancer cell lines. Oncol Rep 32:1981–1990. https://doi.org/10.3892/or.2014.3468

Article  CAS  PubMed  Google Scholar 

Kinross KM, Montgomery KG, Kleinschmidt M et al (2012) An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice. J Clin Invest 122:553–557. https://doi.org/10.1172/JCI59309

Article  CAS  PubMed  PubMed Central  Google Scholar 

Korpos É, Deák F, Kiss I (2015) Matrilin-2, an extracellular adaptor protein, is needed for the regeneration of muscle, nerve and other tissues. Neural Regen Res 10:866–869. https://doi.org/10.4103/1673-5374.158332

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Malley DM (2019) New Therapies for Ovarian Cancer. J Natl Compr Canc Netw 17:619–621. https://doi.org/10.6004/jnccn.2019.5018

Article  CAS  PubMed  Google Scholar 

Penny SM (2020) Ovarian Cancer: an Overview Radiol Technol 91:561–575

PubMed  Google Scholar 

Qin J, Fu M, Wang J et al (2020) PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin-3-gallate in ovarian cancer. Oncol Rep 43:1885–1896. https://doi.org/10.3892/or.2020.7571

Article  CAS  PubMed  PubMed Central  Google Scholar 

Russo A, Czarnecki AA, Dean M et al (2018) PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation. Oncogene 37:1976–1990. https://doi.org/10.1038/s41388-017-0097-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma MK, Watson MA, Lyman M et al (2006) Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma. Neurology 66:127–130. https://doi.org/10.1212/01.wnl.0000188667.66646.1c

Article  CAS  PubMed  Google Scholar 

Shi M, Whorton AE, Sekulovski N et al (2020) Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis. Biol Reprod 102:1055–1064. https://doi.org/10.1093/biolre/ioaa008

Article  PubMed  PubMed Central  Google Scholar 

Szabó E, Korpos E, Batmunkh E et al (2008) Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma. Pathol Oncol Res 14:15–22. https://doi.org/10.1007/s12253-008-9005-4

Article  CAS  PubMed  Google Scholar 

Wang J, Xu W, He Y et al (2018) LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN. Inflamm Res 67:927–936. https://doi.org/10.1007/s00011-018-1186-z

Article  CAS  PubMed  Google Scholar 

Wang P, Xiao WS, Li YH et al (2021) Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining. Dis Markers 2021:1769635. https://doi.org/10.1155/2021/1769635

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Zhang Z, Kou Z (2021) Pentamidine Inhibits Ovarian Cancer Cell Proliferation and Migration by Maintaining Stability of PTEN in vitro. Drug Des Devel Ther 15:2857–2868. https://doi.org/10.2147/DDDT.S311187

Article  PubMed  PubMed Central  Google Scholar 

Xie F, Wang J, Zhang B (2023) RefFinder: a web-based tool for comprehensively analyzing and identifying reference genes. Funct Integr Genomics 23:125. https://doi.org/10.1007/s10142-023-01055-7

Article  CAS  PubMed  Google Scholar 

Yao X, Yu S, Jing X et al (2020) PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway. Stem Cell Res Ther 11:140. https://doi.org/10.1186/s13287-020-01658-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Z, Li X, Yang B et al (2023) SORL1 stabilizes ABCB1 to promote cisplatin resistance in ovarian cancer. Funct Integr Genomics 23:147. https://doi.org/10.1007/s10142-023-01075-3

Article  CAS  PubMed  Google Scholar